StockData
Elite Pharmaceuticals Inc logo

Elite Pharmaceuticals Inc (ELTP) stock

ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$0.25−0.00 (-1.37%)

Close on Oct 19, 2026Market cap $283.02MP/E 5.0Yield –

Elite Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Elite Pharmaceuticals's price to book ratio was 2.6× on Oct 19, 2026, against 13.8× a year earlier. Over the last 5 years it ranged from 1.0× to 15.4×, with a median of 3.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20262.6×−6.0
2025Dec 31, 20258.5×−3.7
2024Dec 31, 202412.2×+9.1
2023Dec 29, 20233.1×+2.0
2022Dec 30, 20221.1×−0.4
2021Dec 31, 20211.5×−2.0
2020Dec 31, 20203.5×−38.1
2019Jan 31, 201941.5×+9.2
2018Dec 31, 201832.3×+20.9
2017Dec 29, 201711.4×+5.5
2016Dec 30, 20166.0×–

More Elite Pharmaceuticals figures

See a number that looks wrong?